Skip to main content

Want a detailed portfolio tracker?

Alumis (ALMS) P/E (2024 - 2026)

Alumis (ALMS) P/E from Jun 28, 2024 to Jul 21, 2026. The TTM Alumis (ALMS) P/E is -10.52. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Alumis (ALMS)

YearP/EChange
2026-10.52+314.46%
2025-2.54+1433.58%
2024-0.17N/A

Comparison Alumis (ALMS) P/E with competitors

Alumis (ALMS) P/E is -10.52.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.71%
FGENFibroGen Inc0.24-102.28%
CHRSCoherus Biosciences Inc0.85-108.06%
FBIOFortress Biotech Inc0.95-109.02%
ORMPOramed Pharmaceuticals Inc1.50-114.28%
AGENAgenus Inc3.01-128.60%
INVAInnoviva Inc3.15-129.97%
VXRTVaxart Inc3.55-133.73%
CRMDCorMedix Inc3.63-134.48%
CVACCureVac N.V.4.45-142.24%
GLPGGalapagos NV4.86-146.17%
SRPTSarepta Therapeutics Inc4.88-146.39%
ABEOAbeona Therapeutics Inc5.39-151.19%
ABUSArbutus Biopharma Corp5.60-153.17%
ZVRAZevra Therapeutics Inc5.89-155.94%
SPROSpero Therapeutics Inc6.23-159.18%
CGENCompugen Ltd6.31-159.99%
RIGLRigel Pharmaceuticals6.87-165.30%
SLXNSilexion Therapeutics Corp7.30-169.32%
OMEROmeros Corporation9.26-187.97%
AUPHAurinia Pharmaceuticals Inc9.58-191.07%
PLXProtalix BioTherapeutics Inc10.89-203.48%
ACADAcadia Pharmaceuticals Inc11.73-211.44%
TBPHTheravance Biopharma Inc12.26-216.51%
ADMAAdma Biologics Inc12.42-217.99%
HRMYHarmony Biosciences Holdings Inc13.82-231.32%
SABSSAB Biotherapeutics Inc14.14-234.32%
NAGENiagen Bioscience Inc14.82-240.80%
INCYIncyte Corp15.82-250.34%
REGNRegeneron Pharmaceuticals Inc15.86-250.67%
PBYIPuma Biotechnology Inc17.32-264.53%
CPRXCatalyst Pharmaceuticals Inc17.44-265.70%
EXELExelixis Inc17.54-266.64%
TGTXTG Therapeutics Inc18.97-280.21%
MDXGMimedx Group Inc20.55-295.28%
XOMAXOMA Royalty Corp22.87-317.35%
ARGXArgen X SE24.30-330.88%
CTMXCytomX Therapeutics Inc24.82-335.85%
XOMAOXOMA Royalty Corp25.34-340.83%
HALOHalozyme Therapeutics Inc25.62-343.48%
XOMAPXOMA Royalty Corp25.67-343.92%
VRTXVertex Pharmaceuticals Inc27.99-366.00%
RPRXRoyalty Pharma plc - Class A28.69-372.59%
SLNOSoleno Therapeutics Inc29.02-375.70%
ASNDAscendis Pharma A/S30.09-385.87%
LGNDLigand Pharmaceuticals Inc - Class B37.91-460.24%
APLSApellis Pharmaceuticals Inc39.02-470.78%
BMRNBiomarin Pharmaceutical Inc42.21-501.09%
KRYSKrystal Biotech Inc45.34-530.85%
ONCBeiGene Ltd69.54-760.77%
PHARPharming Group N.V.75.03-812.89%
TECHBio-Techne Corp101.96-1068.80%
VCELVericel Corp109.92-1144.47%
GMABGenmab140.29-1433.04%
TLXTelix Pharmaceuticals Ltd162.15-1640.77%
CORTCorcept Therapeutics Inc212.86-2122.56%